ArticleClinical drug investigation2020

Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia.

Masnoon Saiyed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.